![Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology](https://media.americanpharmaceuticalreview.com/m/28/article/587062.jpg)
Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
![Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates - Merck .com Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates - Merck .com](https://www.merck.com/wp-content/themes/mhh-merck-mco-theme/images/news-release-opt-in-image-.png?resize=516,596)
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates - Merck .com
![PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) | A Treatment for HER2-Positive Breast Cancer PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) | A Treatment for HER2-Positive Breast Cancer](https://www.phesgo.com/content/dam/gene/phesgo/logo/PHESGO-US-Logo-RGB-2021.genecoreimg.1200.png)
PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) | A Treatment for HER2-Positive Breast Cancer
![Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology](https://media.americanpharmaceuticalreview.com/m/28/article/587062-m1.jpg)
Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
![Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology](https://media.americanpharmaceuticalreview.com/m/28/article/587062-2.jpg)
Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology
![Jacobio Pharma to Collaborate with Merck on Clinical Trial of JAB-21822 in Combination with Cetuximab Jacobio Pharma to Collaborate with Merck on Clinical Trial of JAB-21822 in Combination with Cetuximab](https://mma.prnewswire.com/media/1474816/Logo.jpg?p=facebook)
Jacobio Pharma to Collaborate with Merck on Clinical Trial of JAB-21822 in Combination with Cetuximab
![Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology Long-Acting Injectable Suspensions | American Pharmaceutical Review - The Review of American Pharmaceutical Business & Technology](https://media.americanpharmaceuticalreview.com/m/28/article/587062-t1.jpg)